PhaseV Demonstrates How AI-Driven Site Selection and Real-Time Analytics Reduce Recruitment Uncertainty and Accelerate IBD Clinical Trials
Poster Presentation at the 2026 Crohn’s & Colitis Congress® Showcases Use of Causal Machine Learning and IBD Plexus® to Optimize Trial Execution PhaseV, a leader in AI/ML for clinical development, is today presenting new study results demonstrating its ability to improve inflammatory bowel disease (IBD) trial efficiency at the 2026 Crohn’s & Colitis Congress in […]